Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Change in Acquisitions & Divestments (2021 - 2025)

Historic Change in Acquisitions & Divestments for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to $30.0 million.

  • Kezar Life Sciences' Change in Acquisitions & Divestments fell 3190.18% to $30.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $126.5 million, marking a year-over-year decrease of 3877.1%. This contributed to the annual value of $171.8 million for FY2024, which is 3347.76% down from last year.
  • Per Kezar Life Sciences' latest filing, its Change in Acquisitions & Divestments stood at $30.0 million for Q3 2025, which was down 3190.18% from $39.7 million recorded in Q2 2025.
  • In the past 5 years, Kezar Life Sciences' Change in Acquisitions & Divestments ranged from a high of $85.2 million in Q4 2022 and a low of $13.8 million during Q1 2025
  • For the 5-year period, Kezar Life Sciences' Change in Acquisitions & Divestments averaged around $46.5 million, with its median value being $43.8 million (2021).
  • As far as peak fluctuations go, Kezar Life Sciences' Change in Acquisitions & Divestments soared by 35825.51% in 2023, and later tumbled by 6357.62% in 2025.
  • Quarter analysis of 5 years shows Kezar Life Sciences' Change in Acquisitions & Divestments stood at $31.0 million in 2021, then skyrocketed by 175.0% to $85.2 million in 2022, then fell by 8.8% to $77.8 million in 2023, then tumbled by 44.71% to $43.0 million in 2024, then tumbled by 30.22% to $30.0 million in 2025.
  • Its last three reported values are $30.0 million in Q3 2025, $39.7 million for Q2 2025, and $13.8 million during Q1 2025.